8 Amendments of Petros KOKKALIS related to 2021/2013(INI)
Amendment 93 #
Motion for a resolution
Recital Γ a (new)
Recital Γ a (new)
Ca. whereas ensuring that patients have access to affordable essential medicines is one of the core objectives of the EU, the WHO and UN Sustainable Development Goal 3;
Amendment 107 #
Motion for a resolution
Recital Γ b (new)
Recital Γ b (new)
Cb. whereas universal access to medicines, which is a basic right for all without discrimination, depends on their availability when needed and their affordability;
Amendment 115 #
Motion for a resolution
Recital Γ c (new)
Recital Γ c (new)
Cc. whereas, in many cases, the price of new innovative medicines is extremely high, to the point of being unaffordable for many European citizens and also threatening the sustainability of national health care systems;
Amendment 145 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Points out that healthcare is a human right enshrined in the Universal Declaration of Human Rights; points out that equal access to medicines must be ensured in order to uphold this right;
Amendment 269 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Calls on the Commission to review the incentive system, increase price transparency, highlight the causes limiting affordability and patient access to medicinal products, and propose sustainable solutions that also promote competition; calls on the Commission and the national competition authorities to monitor unfair practices in order to protect consumers from artificially inflated drug prices;
Amendment 430 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Expresses concern that certain groups at particular risk of social exclusion and particularly affected by the COVID-19 pandemic have difficulty in accessing treatment and other services aimed at eradicating infectious diseases such as HIV/AIDS, hepatitis C and B and tuberculosis; calls on the Commission and the ECDC, working to a single timetable with an agreed set of guidelines/ good practices, to invite Member States to draw up integrated action plans to improve access, focusing on cooperation between state and non-state actors in reaching out to those concerned;
Amendment 710 #
Motion for a resolution
Paragraph 23 a (new)
Paragraph 23 a (new)
23a. Stresses that the WTO TRIPS Agreement offers flexibility with regard to patent rights, for example through compulsory licensing, thereby bringing down prices substantially; points out that this flexibility can be effectively turned to account to address public health concerns in exceptional circumstances, enabling the necessary medicines to be supplied at affordable prices as part of domestic policy aimed at promoting public health;
Amendment 715 #
Motion for a resolution
Paragraph 23 b (new)
Paragraph 23 b (new)
23b. Calls for EU initiatives to provide patients with equal access to medicines at global level;